Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Mallinckrodt
AstraZeneca
Harvard Business School
Express Scripts

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GRALISE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Gralise

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01067144 ↗ Stanford Accelerated Recovery Trial (START) Terminated Stanford University Phase 3 2010-05-01 The goal of this study is to determine whether administering Gabapentin prior to surgery affects duration of pain and opioid use post-surgery. The investigators aim to compare gabapentin to placebo in a prospective, randomized clinical trial in which patients will be followed post-surgery until pain resolves and opioid use ceases.
NCT01301001 ↗ A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee Health Science Center N/A 2012-08-01 The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01301001 ↗ A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response Completed University of Tennessee N/A 2012-08-01 The Specific aims of this project are to (1) test the prediction that pain from tampon insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin compared to when treated with placebo. Secondary outcome measures include intercourse pain and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more specific treatment options.
NCT01533753 ↗ Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer Terminated University of Wisconsin, Madison Phase 2 2012-02-01 The purpose of this study is to assess the change in quality of life over a 6 month period between gabapentin and venlafaxine in men with prostate cancer treated for hot flashes related to androgen deprivation therapy.
NCT01623271 ↗ Treatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise) Terminated Massachusetts General Hospital N/A 2013-05-01 The purpose of this study is to see if an FDA-approved drug (Gralise) can help people with certain types of neuropathic pain without causing too many side effects.
NCT01675960 ↗ Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children Terminated Gillette Children's Specialty Healthcare Phase 2 2012-04-01 This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources.
NCT01675960 ↗ Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children Terminated Scott Schwantes, M.D. Phase 2 2012-04-01 This study is a prospective, randomized, double blind, placebo controlled, crossover clinical trial looking at whether gabapentin can provide symptom relief for chronic irritability in neurologically impaired children. The investigators hypothesize gabapentin ins beneficial and safe for children with chronic irritability that persists despite identification and appropriate management of symptom sources.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gralise

Condition Name

Condition Name for Gralise
Intervention Trials
Pain 3
Mucositis 1
Radiation-Induced Disorder 1
Complex Regional Pain Syndrome I (CRPS I) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Gralise
Intervention Trials
Head and Neck Neoplasms 4
Somatoform Disorders 2
Squamous Cell Carcinoma of Head and Neck 2
Pain, Postoperative 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gralise

Trials by Country

Trials by Country for Gralise
Location Trials
United States 18
Lebanon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Gralise
Location Trials
New York 4
Illinois 2
Massachusetts 2
Tennessee 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gralise

Clinical Trial Phase

Clinical Trial Phase for Gralise
Clinical Trial Phase Trials
Phase 4 6
Phase 3 4
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Gralise
Clinical Trial Phase Trials
Completed 9
Terminated 6
Unknown status 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gralise

Sponsor Name

Sponsor Name for Gralise
Sponsor Trials
National Cancer Institute (NCI) 4
Massachusetts General Hospital 2
Roswell Park Cancer Institute 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Gralise
Sponsor Trials
Other 20
NIH 4
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Johnson and Johnson
McKesson
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.